Biogen (BIIB) Construction in Progress (2009 - 2025)

Biogen has reported Construction in Progress for 17 years, with the latest figure at $163.1 million in Q4 2025.

• On a quarterly basis, Construction in Progress fell 47.11% year-over-year to $163.1 million in Q4 2025; TTM through Dec 2025 was $163.1 million, a 47.11% decrease from a year earlier, with the FY2025 full-year figure at $163.1 million, down 47.11% from the prior year.
• Construction in Progress was $163.1 million for Q4 2025 at Biogen, down from $308.4 million in the prior quarter.
• The five-year high for Construction in Progress was $1.9 billion in Q1 2021, with the low at $163.1 million in Q4 2025.
• Average Construction in Progress over 5 years is $754.1 million, with a median of $711.1 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2024: Construction in Progress grew 15.38% in 2022, then slumped 68.38% in 2024.
• Over 5 years, Construction in Progress stood at $770.3 million in 2021, then gained by 15.38% to $888.8 million in 2022, then grew by 9.74% to $975.4 million in 2023, then sank by 68.38% to $308.4 million in 2024, then plunged by 47.11% to $163.1 million in 2025.
• The last three Construction in Progress figures came in at $163.1 million (Q4 2025), $308.4 million (Q4 2024), and $975.4 million (Q4 2023), per Business Quant data.